• 1. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 2. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
• 3. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 4. Fe3O4/FeS2 heterostructures enable efficient oxygen evolution reaction?
  Xingqun Zheng,Lele Song,Xin Feng,Li Li,Zidong Wei J. Mater. Chem. A, 2020,8, 14145-14151
• 5. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555

Introduction to 2-Chloro-5-methoxyquinazoline (CAS No: 1253654-39-5)

2-Chloro-5-methoxyquinazoline, identified by its Chemical Abstracts Service (CAS) number 1253654-39-5, is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical and medicinal chemistry. This compound belongs to the quinazoline class, a scaffold that is widely recognized for its biological activity and potential therapeutic applications. The presence of both chloro and methoxy substituents on the quinazoline ring system imparts unique electronic and steric properties, making it a valuable intermediate in the synthesis of various bioactive molecules.

The structural features of 2-Chloro-5-methoxyquinazoline contribute to its versatility as a building block in drug discovery. The chloro group at the 2-position enhances electrophilicity, facilitating nucleophilic substitution reactions, while the methoxy group at the 5-position introduces hydrophilicity and modulates electronic distribution. These characteristics are particularly useful in designing molecules that target specific biological pathways, such as kinases and other enzymes involved in cancer metabolism.

In recent years, quinazoline derivatives have been extensively studied for their potential as anticancer agents. Several preclinical studies have demonstrated the efficacy of compounds derived from 2-Chloro-5-methoxyquinazoline in inhibiting the activity of tyrosine kinases, which are overexpressed in many solid tumors. The ability of this compound to disrupt signaling pathways associated with cell proliferation and survival makes it a promising candidate for further development into novel therapeutic agents.

One of the most compelling aspects of 2-Chloro-5-methoxyquinazoline is its role as a precursor in the synthesis of more complex quinazoline-based drugs. Researchers have leveraged its reactive sites to develop molecules with enhanced pharmacological profiles. For instance, by introducing additional functional groups or appending different pharmacophores, chemists have generated libraries of compounds that exhibit improved solubility, bioavailability, and target specificity. These efforts align with the broader goal of developing next-generation anticancer therapies that address limitations associated with existing treatments.

The chemical synthesis of 2-Chloro-5-methoxyquinazoline involves multi-step reactions that typically begin with readily available starting materials. A common synthetic route includes the condensation of an appropriate aromatic amine with a carbonyl compound, followed by chlorination and methylation at specific positions on the quinazoline core. Advances in synthetic methodologies have enabled more efficient and scalable production processes, which are crucial for both academic research and industrial applications.

From a medicinal chemistry perspective, 2-Chloro-5-methoxyquinazoline serves as a key intermediate in the development of small molecule inhibitors targeting various diseases beyond cancer. Its structural motif is found in several FDA-approved drugs used to treat conditions such as hypertension and inflammation. The adaptability of this scaffold allows medicinal chemists to fine-tune its properties for specific therapeutic needs, underscoring its importance in drug design.

The pharmacokinetic behavior of derivatives of 2-Chloro-5-methoxyquinazoline has been thoroughly investigated to optimize their delivery and efficacy. Studies have focused on improving metabolic stability, reducing off-target effects, and enhancing tissue penetration. These efforts are critical for translating promising preclinical findings into effective clinical treatments. By modulating physicochemical properties such as lipophilicity and polar surface area, researchers aim to develop compounds that exhibit favorable pharmacokinetic profiles.

Recent advancements in computational chemistry have further accelerated the discovery process for 2-Chloro-5-methoxyquinazoline derivatives. Molecular modeling techniques allow researchers to predict binding affinities, identify potential drug candidates, and optimize molecular structures before experimental synthesis. This integration of computational methods with traditional wet chemistry has significantly reduced the time and resources required for drug development.

The role of 2-Chloro-5-methoxyquinazoline in addressing unmet medical needs cannot be overstated. Its versatility as a synthetic intermediate has enabled the creation of novel therapeutics that target previously untreatable conditions. As our understanding of disease mechanisms continues to evolve, compounds derived from this scaffold are likely to play an increasingly important role in modern medicine.

In conclusion,2-Chloro-5-methoxyquinazoline (CAS No: 1253654-39-5) is a multifaceted compound with significant potential in pharmaceutical research and development. Its unique structural features make it an invaluable tool for designing molecules with tailored biological activities. With ongoing research efforts aimed at optimizing its properties and exploring new applications,2-Chloro-5-methoxyquinazoline is poised to remain at the forefront of medicinal chemistry innovation.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)